New Delhi: Mumbai-based revenue cycle management solutions provider Infinx has acquired US-based prior authorisation processing firm Glidian for an undisclosed amount.
In a statement, Infinx announced that both companies have built integrations with several nationwide payers. By merging these connections, the combined entity aims to enhance efficiencies and streamline workflows for customers.
Together, Infinx and Glidian now process an average of 700,000 patient access transactions per month, reinforcing their position as a leader in patient access automation.
Commenting on the acquisition, Jaideep Tandon, CEO, Infinx, said, “Glidian’s expertise in prior authorisation technology, particularly in the laboratory space, complements Infinx’s suite of patient access solutions. We’re excited to welcome the Glidian team to the Infinx family and look forward to driving continued innovation to address challenges in patient access and prior authorisation.”
Ashish Dua, CEO , Glidian, added, “With Infinx’s resources and expertise, we can further accelerate prior authorization automation and expand our product offerings, ultimately improving the patient access experience.”
The acquisition strengthens Infinx’s foothold in the laboratory market, where Glidian has achieved comprehensive market coverage. By combining Infinx’s AI-driven platform with Glidian’s established solutions, customers can expect a seamless and more efficient prior authorisation process.
